Markov Chain Models in Clinical Performance and Decision Making

Read full text Summarise with VIRAT
Authors: Guanjie Zhao
Cited by: 0
References: 14

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Within clinical research and healthcare decision-making, stochastic modeling methods are becoming increasingly more necessary due to the complexity of predicting the results of clinical processes, disease progression, and analyzing the effectiveness of various treatments. Markov chain models in particular present a good mix of accuracy and simplicity for modeling healthcare outcomes. This study presents a detailed overview of the theoretical foundations of Markov chain models while also discussing their application in patient risk stratification, clinical decision-making, and cost-effectiveness analysis of treatments. Both the advantages and disadvantages of Markov chain models like the memoryless assumption, data requirements needed, and state complexity particularly in healthcare contexts, are examined. Possible future directions for Markov chain modeling, namely hybrid modeling approaches and Markov decision processes (MDPs), are assessed to compare their ability to improve predictive accuracy and influence healthcare policies with regular Markov chain models. Combined all the elements, this study offers clinical researchers and policymakers a comprehensive reference on the strengths and weaknesses of Markov chain modeling specifically in healthcare applications.

Fields of Study & Subjects

Probability and Statistical Research Health Systems Economic Evaluations Quality of Life Statistical Methods in Epidemiology

Publication details

Journal / source
Theoretical and Natural Science
Volume
163
Issue
1
Pages
8–13
Publication date
30 March 2026
Language
EN